Lv3
290 积分 2026-01-05 加入
Personalized Medicine for PLA2R1-Related Membranous Nephropathy: A Multicenter Randomized Control Trial
13天前
已完结
Rituximab for Idiopathic Membranous Nephropathy
13天前
已完结
Combined Plasmatic and Tissue Approach to Membranous Nephropathy—Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach
13天前
已完结
SaO022EFFECT OF BELIMUMAB ON PROTEINURIA AND ANTI-PLA2R AUTOANTIBODY IN IDIOPATHIC MEMBRANOUS NEPHROPATHY - 6 MONTHS DATA
13天前
已完结
PLA2R Autoantibodies and Glomerular PLA2R Deposit in Membranous Nephropathy: How to Evaluate the Roles they Played?
13天前
已完结
Effect of Single-Dose Rituximab on Primary Glomerular Diseases
13天前
已完结
Association between anti-rituximab antibodies and treatment efficacy of rituximab in membranous nephropathy
13天前
已完结
A novel dosing approach for rituximab in glomerular diseases based on a population pharmacokinetic analysis
13天前
已完结
Revisiting Anti-phospholipase A2 Receptor Antibodies and Its Antigen as Specific Biomarkers in Idiopathic Membranous Nephropathy
13天前
已完结
皖公网安备34019202002308
